May 19, 2009 — Oral iron-chelation products have been heavily promoted for use in patients with myelodysplastic syndrome (MDS) and, recently, in patients with primary myelofibrosis (PMF), but this use ...

Iron chelation therapy refers to a technique that reduces the iron levels and incidence of stroke and cardiac events associated with repeated blood transfusions required for the long-term treatment of ...

Brain iron chelation with deferiprone was associated with worse parkinsonism symptoms and adverse events in early Parkinson's disease, the FAIRPARK-II trial showed. From baseline to week 36, mean ...

Iron Chelation Therapy Fails to Prevent Reperfusion Injury After STEMI Adjunctive chelation therapy with deferoxamine after the onset of ischemia in patients treated by primary percutaneous coronary ...

Oncotarget published "Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia" which reported that the standard treatment for pediatric AML currently consists in a ...

Starting iron chelation therapy early may prevent growth problems and organ damage from iron overload in children with TDT. Currently approved medications have limitations for use in very young ...

Age-specific differences in oncogenic pathway deregulation and chemosensitivity in patients with acute myeloid leukemia: Strategies to maximize response to induction chemotherapy No significant ...

Myelodysplastic syndromes (MDS) often require frequent blood transfusions for anemia, which can lead to iron overload. Over time, extra iron can damage organs throughout the body. Underlying MDS ...

Research indicates that patients with transfusion-dependent thalassemia often experience decreased muscle mass and strength compared to healthy ...

Experts believe that increasing air pollution in cities is having a serious impact on the health of thalassemia patients.